Drugs / rF1V-1018
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07207408 | Sep 2025 → Jan 2027 expected | plague | Dynavax Technologies Corporation | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rF1V-1018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07207408 ↗ |
| Modality | Vaccine | “rF1V-1018 vaccine” NCT07207408 ↗ |